CMG Pharmaceutical Co., Ltd. (KOSDAQ:058820)
South Korea
· Delayed Price · Currency is KRW
1,725.00
-75.00 (-4.17%)
Mar 9, 2026, 3:30 PM KST
CMG Pharmaceutical Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2019 | FY 2018 |
| Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 |
| Market Capitalization | 255,028 | 245,561 | 334,730 | 298,618 | 590,292 | 461,137 | |
| Market Cap Growth | -1.97% | -26.64% | 12.09% | -49.41% | 28.01% | -32.13% | |
| Enterprise Value | 285,839 | 239,371 | 285,069 | 182,746 | 466,997 | 406,460 | |
| Last Close Price | 1725.00 | 1768.00 | 2410.00 | 2150.00 | 4250.00 | 3945.03 | |
| PE Ratio | - | 91.13 | 51.85 | - | 193.46 | 76.03 | |
| PS Ratio | 2.54 | 2.48 | 3.56 | 3.63 | 10.07 | 9.25 | |
| PB Ratio | 1.25 | 1.30 | 1.76 | 1.62 | 3.28 | 4.43 | |
| P/TBV Ratio | 1.29 | 1.33 | 1.82 | 1.64 | 3.30 | 4.48 | |
| P/OCF Ratio | - | 846.50 | 84.99 | 60.48 | 209.07 | 520.01 | |
| EV/Sales Ratio | 2.85 | 2.42 | 3.04 | 2.22 | 7.97 | 8.15 | |
| EV/EBITDA Ratio | - | 54.82 | 50.96 | 34.71 | 99.16 | 92.05 | |
| EV/EBIT Ratio | - | 234.60 | 93.87 | 61.30 | 179.35 | 158.17 | |
| EV/FCF Ratio | -8.04 | - | - | - | - | - | |
| Debt / Equity Ratio | 0.35 | 0.42 | 0.14 | 0.04 | 0.00 | - | |
| Debt / EBITDA Ratio | - | 18.31 | 4.67 | 1.27 | 0.06 | - | |
| Net Debt / Equity Ratio | 0.15 | 0.02 | -0.22 | -0.38 | -0.66 | -0.52 | |
| Net Debt / EBITDA Ratio | -29.67 | 0.73 | -7.63 | -13.50 | -25.33 | -12.33 | |
| Net Debt / FCF Ratio | -0.87 | -0.11 | 5.06 | 20.64 | 22.29 | 32.83 | |
| Asset Turnover | 0.33 | 0.36 | 0.41 | - | 0.38 | 0.45 | |
| Inventory Turnover | 1.73 | 2.41 | 2.40 | - | 3.38 | 3.30 | |
| Quick Ratio | 0.72 | 3.47 | 3.80 | 4.58 | 15.12 | 8.50 | |
| Current Ratio | 1.08 | 4.29 | 4.72 | 6.17 | 16.18 | 9.58 | |
| Return on Equity (ROE) | -4.79% | 1.42% | 3.44% | - | 2.15% | 6.01% | |
| Return on Assets (ROA) | -0.87% | 0.23% | 0.83% | - | 1.06% | 1.43% | |
| Return on Invested Capital (ROIC) | -1.94% | 0.56% | 2.23% | 3.41% | 3.74% | 5.68% | |
| Return on Capital Employed (ROCE) | -2.10% | 0.40% | 1.40% | 1.60% | 1.40% | 2.40% | |
| Earnings Yield | -3.76% | 1.10% | 1.93% | -0.13% | 0.52% | 1.31% | |
| FCF Yield | -13.94% | -11.32% | -2.52% | -1.15% | -0.91% | -0.36% | |
| Payout Ratio | - | - | 0.45% | - | - | - | |
| Buyback Yield / Dilution | 16.18% | -13.12% | - | -14.27% | -11.63% | 0.14% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.